11/08/2024
5:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
5:13 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
12:54 PM | VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
5:31 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:48 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:37 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
6:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/25/2024
6:28 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:09 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
11:26 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024
8:20 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
8:21 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:29 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
6:23 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
6:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:11 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:13 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
7:00 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:47 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
7:03 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:38 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:05 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
4:55 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:56 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/30/2024
4:58 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:10 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
6:10 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
6:46 PM | Viking Therapeutics (Filer)
| Form S-8 POS | |
05/22/2024
6:54 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
3:33 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
7:51 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:04 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
8:27 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
3:02 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
7:42 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
⭕ [URGENT] Buy Alert just triggered (Ad) My absolute favorite stock just hit a critical "buy now" trigger price. Click here for the ticker >>> |
04/05/2024
3:15 PM | Viking Therapeutics (Filer)
| Form ARS | |
03/27/2024
7:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:51 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
7:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:08 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
6:50 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:52 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:54 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:52 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
3:05 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
4:21 PM | Viking Therapeutics (Filer)
| Form 424B5 | |
02/27/2024
6:04 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:59 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:38 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:40 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
4:24 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/07/2024
4:33 PM | Viking Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/31/2024
7:39 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:32 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
8:05 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:23 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
12:24 PM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/19/2024
7:35 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:36 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:26 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
01/04/2024
8:35 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:36 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:37 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:22 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:24 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:25 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:27 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
8:28 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
7:12 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
